Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.819 USD | +1.24% | +2.12% | -26.22% |
03-15 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-14 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
Sales 2024 * | 40.31M 55.1M | Sales 2025 * | 47.76M 65.28M | Capitalization | 44.48M 60.8M |
---|---|---|---|---|---|
Net income 2024 * | -20M -27.34M | Net income 2025 * | -9M -12.3M | EV / Sales 2024 * | 1.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.93 x |
P/E ratio 2024 * |
-2.28
x | P/E ratio 2025 * |
-4.03
x | Employees | 186 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.62% |
Latest transcript on Cytosorbents Corporation
1 day | +1.24% | ||
1 week | +2.12% | ||
Current month | -13.79% | ||
1 month | -7.98% | ||
3 months | -17.27% | ||
6 months | -50.66% | ||
Current year | -26.22% |
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.819 | +1.24% | 96,079 |
24-04-25 | 0.809 | -1.55% | 46,377 |
24-04-24 | 0.8217 | -6.52% | 181,165 |
24-04-23 | 0.879 | +8.52% | 108,104 |
24-04-22 | 0.81 | +1.00% | 97,907 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.22% | 44.48M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- CTSO Stock